These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12086697)

  • 1. A lipoprotein lipase activator, NO-1886 prevents impaired endothelium-dependent relaxation of aorta caused by exercise in aged rats.
    Kusunoki M; Tsutsumi K; Hara T; Ogawa H; Nakamura T; Miyata T; Sakakibara F; Fukuzawa Y; Suga T; Kakumu S; Nakaya Y
    Exp Gerontol; 2002 Jul; 37(7):891-6. PubMed ID: 12086697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging.
    Hara T; Kusunoki M; Tsutsumi K; Okada K; Sakamoto S; Ohnaka M; Nakamura T; Miyata T; Nakayama K; Fukatsu A; Kato K; Kakumu S; Nakaya Y
    Eur J Pharmacol; 1998 May; 350(1):75-9. PubMed ID: 9683017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise improved accumulation of visceral fat and simultaneously impaired endothelium-dependent relaxation in old rats.
    Tsutsumi K; Kusunoki M; Hara T; Okada K; Sakamoto S; Ohnaka M; Nakay Y
    Biol Pharm Bull; 2001 Jan; 24(1):88-91. PubMed ID: 11201252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbits.
    Yin W; Tsutsumi K; Yuan Z; Yang B
    Arzneimittelforschung; 2002; 52(8):610-4. PubMed ID: 12236049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the lipoprotein lipase activator NO-1886 on adriamycin-induced nephrotic syndrome in rats.
    Nakayama K; Hara T; Kusunoki M; Tsutsumi K; Minami A; Okada K; Sakamoto S; Ohnaka M; Miyata T; Nakamura T; Aoki T; Fukatsu A; Nakaya Y; Kakumu S
    Metabolism; 2000 May; 49(5):588-93. PubMed ID: 10831167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exercise on plasma lipoprotein levels and endothelium-dependent vasodilatation in young and old rats.
    Hashimoto M
    Eur J Appl Physiol Occup Physiol; 1990; 61(5-6):440-5. PubMed ID: 2079064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous NIDDM.
    Sakamoto S; Minami K; Niwa Y; Ohnaka M; Nakaya Y; Mizuno A; Kuwajima M; Shima K
    Diabetes; 1998 Jan; 47(1):82-6. PubMed ID: 9421378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein lipase and atherosclerosis.
    Tsutsumi K
    Curr Vasc Pharmacol; 2003 Mar; 1(1):11-7. PubMed ID: 15320848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein lipase activator NO-1886.
    Yin W; Tsutsumi K
    Cardiovasc Drug Rev; 2003; 21(2):133-42. PubMed ID: 12847564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
    Kusunoki M; Tsutsumi K; Hara T; Ogawa H; Nakamura T; Miyata T; Sakakibara F; Fukuzawa Y; Suga T; Kakumu S; Nakaya Y
    Metabolism; 2002 Jun; 51(6):792-5. PubMed ID: 12037738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats.
    Kusunoki M; Tsutsumi K; Inoue Y; Hara T; Miyata T; Nakamura T; Ogawa H; Sakakibara F; Fukuzawa Y; Okabayashi N; Kato K; Ikeda H; Kurokawa T; Ishikawa T; Otake K; Nakaya Y
    Metabolism; 2004 Feb; 53(2):260-3. PubMed ID: 14767881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO-1886, a lipoprotein lipase activator, attenuates vascular smooth muscle contraction in rat aorta.
    Nakamura A; Harada N; Takahashi A; Mawatari K; Nakano M; Tsutsumi K; Nakaya Y
    Eur J Pharmacol; 2007 Jan; 554(2-3):183-90. PubMed ID: 17109854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group.
    Karasu C; Ozansoy G; Bozkurt O; Erdoğan D; Omeroğlu S
    Metabolism; 1997 Aug; 46(8):872-9. PubMed ID: 9258267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886.
    Kusunoki M; Tsutsumi K; Sato D; Nakamura A; Habu S; Mori Y; Morishita M; Yonemoto T; Miyata T; Nakaya Y; Nakamura T
    Eur J Pharmacol; 2011 Oct; 668(3):486-91. PubMed ID: 21835171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet.
    Kusunoki M; Hara T; Tsutsumi K; Nakamura T; Miyata T; Sakakibara F; Sakamoto S; Ogawa H; Nakaya Y; Storlien LH
    Diabetologia; 2000 Jul; 43(7):875-80. PubMed ID: 10952460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs.
    Liu Y; Wang ZB; Yin WD; Li QK; Cai MB; Yu J; Li HG; Zhang C; Zu XH
    Lipids Health Dis; 2011 Jul; 10():117. PubMed ID: 21762526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NO-1886 (ibrolipim), a lipoprotein lipase-promoting agent, accelerates the expression of UCP3 messenger RNA and ameliorates obesity in ovariectomized rats.
    Kano S; Doi M
    Metabolism; 2006 Feb; 55(2):151-8. PubMed ID: 16423620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Carnitine supplementation impairs endothelium-dependent relaxation in mesenteric arteries from rats.
    Valgas da Silva CP; Rojas-Moscoso JA; Antunes E; Zanesco A; Priviero FB
    Arch Physiol Biochem; 2014 Jul; 120(3):112-8. PubMed ID: 24953351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel compound NO-1886 elevates plasma high-density lipoprotein cholesterol levels in hamsters and rabbits by increasing lipoprotein lipase without any effect on cholesteryl ester transfer protein activity.
    Tsutsumi K; Inoue Y; Hagi A; Murase T
    Metabolism; 1997 Mar; 46(3):257-60. PubMed ID: 9054466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
    Kobayashi T; Matsumoto T; Kamata K
    Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.